Combinatorial Chemistry to 2006 - Demand and Sales Forecasts, Market Share, Market Size, Market Leaders
Study #: 1631
Full Study Price: US$ 4,000
Per Page Price: US$ 30.00
Combinatorial Chemistry - Market Research, Market Share, Market Size, Sales, Demand Forecast, Market Leaders, Company Profiles, Industry Trends
US demand for combinatorial products and services will grow over 12 percent yearly through 2006. Advances in assays and instruments will spur growth by improving compound screening and optimization. High throughput imaging systems, cell-based assays, synthesis reagents and virtual screening software will lead gains.
This study analyzes the $2.2 billion combinatorial product and service industry. It presents historical data for 1996 and 2001 and forecasts to 2006 and 2011 by type (e.g., consumables, instruments, software, services); by application (e.g., drug discovery, catalyst development, chemical development, life science research); and by market.
The study also examines the market environment, details industry structure and market share, and profiles 36 participants including Amersham Biosciences, Applera, PerkinElmer, Albany Molecular Research, Molecular Devices, Pharmacopeia, and ArQule.
TABLE OF CONTENTS INTRODUCTION I. EXECUTIVE SUMMARY II. MARKET ENVIRONMENT General Economic Factors Recent Economic Trends Long-Term Economic Projections Demographic Patterns Trends in Health Care Medical Conditions Acute Conditions Chronic Conditions National Health Expenditures Hospital Care & Physicians Services Medical Products Other Personal Health Expenditures Non-Personal Health Expenditures Patient Activity Pharmaceutical Industry Trends Chemical Industry Outlook Plastics Industry Outlook Petroleum Refining Industry Outlook Catalyst Demand International Markets III. TECHNOLOGY OVERVIEW General High Throughput Screening Compound Library Synthesis Compound Purification Competing Technologies IV. PRODUCTS & SERVICES General Consumables Assay Reagents & Test Kits Biochemical & Chemical Assays Cell-Based Assays Compound Libraries Drug Discovery Libraries Catalyst Development Libraries Other Compound Libraries Other Consumables Labeling Materials Synthesis Reagents All Other Combinatorial Chemistry Consumables Instruments Analytical Instruments Imaging Systems Plate Readers Other Combinatorial Chemistry Analytical Instruments Processing Instruments Liquid Handling Systems Plate Processors Other Combinatorial Chemistry Processing Equipment Synthesis Instruments Compound Library Synthesizers Purification Systems Combinatorial Chemistry Software by Type Data Storage & Analysis Virtual Compound Design & Screening Other Combinatorial Chemistry Software Combinatorial Chemistry Software by Application Combinatorial Chemistry Services by Type Systems Design Screening & Analysis Technical Support & Other Combinatorial Chemistry Services by Application V. APPLICATIONS General Drug Discovery Demand Patterns Developmental Activities Amgen AstraZeneca Bayer Pharma Bristol-Myers Squibb ChemCodes GlaxoSmithKline (GSK) Lilly (Eli) Merck & Company Organon Pfizer Schering-Plough Wyeth Catalyst Development Demand Patterns Developmental Activities Chemical Development Demand Patterns Developmental Activities Life Science Research Applications VI. MARKETS General Pharmaceutical Companies Chemical Companies Academic Institutions Other Markets VII. INDUSTRY STRUCTURE General Competitive Trends Market Share Competitive Strategies Licensing & Related Agreements Mergers & Acquisitions Research & Development Marketing & Distribution Company Profiles Advion BioSciences Incorporated Akzo Nobel NV Albany Molecular Research Incorporated Amersham plc Amgen Incorporated Applera Corporation Argonaut Technologies Incorporated ArQule Incorporated AstraZeneca plc Avantium Technologies BV Avecia Group plc Bayer AG Boehringer Ingelheim GmbH Cambrex Corporation Cellomics Incorporated ChemCodes Incorporated Clariant International Limited CuraGen Corporation Discovery Partners International Incorporated Dow Chemical Company DSM NV Exelixis Incorporated GlaxoSmithKline plc hte AG Lilly (Eli) and Company Lonza Group Limited Millennium Pharmaceuticals Incorporated Molecular Devices Corporation Neurogen Corporation PerkinElmer Incorporated Pfizer Incorporated Pharmacia Corporation Pharmacopeia Incorporated Roche Holding Limited Symyx Technologies Incorporated Tripos Incorporated UOP LLCThis table of contents has been truncated and omits a list of tables and charts included in the study. You may view the complete table of contents without charge and select individual records for purchase ($30.00 each) or purchase the complete study.
The Freedonia Group - The First Choice In Industry Research8
© Copyright 2003 The Freedonia Group, Inc.